VANCOUVER  BRITISH COLUMBIA--(CCNMatthews - Jan 24  2007) - Allon Therapeutics Inc (TSX:NPC)  The Neuro Protection Company™  today announced it has received funding from The Michael J Fox Foundation for Parkinson's Research (MJFF) to evaluate the effectiveness of Allon's lead drug AL-108 in pre-clinical models of Parkinson's disease